Peer-reviewedCC BYHeartRhythm case reports
Percutaneous endomyocardial ablation as a septal reduction strategy in symptomatic obstructive hypertrophic cardiomyopathy: A 20-year single-center observational experience.
- 1Department of Cardiac Arrhythmia, St. Vincent's University Hospital, Dublin, Ireland.
Related
- Hypertrophic obstructive cardiomyopathy complicated by severe midventricular obstruction treated with percutaneous transluminal septal myocardial ablation using simultaneous contrast imaging with left ventriculography and coronary angiography: a case report
- Cardiac Myosin Inhibitors in Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-analysis of Randomized Controlled Trials
- A late bloom at the apex: development of apical hypertrophic cardiomyopathy phenotype in advanced age
- Research trends and hotspot analysis of sudden cardiac death in hypertrophic cardiomyopathy : A bibliometric analysis
- Managing a mavacamten non-responder in obstructive hypertrophic cardiomyopathy: A case report
BibTeX
@article{casey2026percutaneous,
title = {{Percutaneous endomyocardial ablation as a septal reduction strategy in symptomatic obstructive hypertrophic cardiomyopathy: A 20-year single-center observational experience.}},
author = {Aoife Casey and John McCormick and David Keane},
journal = {HeartRhythm case reports},
year = {2026},
month = aug,
doi = {10.1016/j.hrcr.2026.07.028},
url = {https://europepmc.org/article/MED/42923702},
note = {CC BY},
}
RIS
TY - JOUR
TI - Percutaneous endomyocardial ablation as a septal reduction strategy in symptomatic obstructive hypertrophic cardiomyopathy: A 20-year single-center observational experience.
AU - Aoife Casey
AU - John McCormick
AU - David Keane
PY - 2026
DA - 2026/08/05
JO - HeartRhythm case reports
DO - 10.1016/j.hrcr.2026.07.028
UR - https://europepmc.org/article/MED/42923702
SN - 2214-0271
ER -